Adinazolam (Deracyn) is a benzodiazepine derivative. It possesses anxiolytic, anticonvulsant, sedative, and antidepressant properties. Adinazolam was developed by Dr. Jackson B. Hester, who was seeking to enhance the antidepressant properties of alprazolam, which he also developed. Adinazolam was never FDA approved and was never available to the public. This product is intended for forensic and research purposes.
- Formula Name: 1-(8-chloro-6-phenyl-4H-[1,2,4]triazolo[4,3-a][1,4]benzodiazepin-1-yl)-N,N-dimethylmethanamine
- CAS: 37115-32-5
- Formula: C19H18ClN5
- Exact Mass: 351.8
- Molecular weight:351.8
- Synonyms:Deracyn, Adinazolamum
- Minimum Quantity order :10g